- Abstract:
-
The adult-onset neurodegenerative disorder amyotrophic lateral sclerosis (ALS) is life-shortening for majority of those affected. Therapeutic trials relying on traditional endpoints such as tracheostomy-free survival, or significant reduction in the slope of decline of the revised ALS Functional Rating Score (ALSFRS-R), entail costly studies which last up to 18 months. Rapid advances in the understanding of the molecular biology of ALS are making the prospect of disease-modifying therapy i...
Expand abstract - Publication status:
- Published
- Peer review status:
- Peer reviewed
- Files:
-
-
(pdf, 140.3KB)
-
- Publisher copy:
- 10.2217/bmm-2018-0149
-
Version unsuitable
-
We have not obtained a suitable full-text for a given research output. See this page for more information.
-
Recently completed
-
Sometimes content is held in ORA but is unavailable for a fixed period of time to comply with the policies and wishes of rights holders.
-
Permissions
-
All content made available in ORA should comply with relevant rights, such as copyright. See this page for more information.
-
Clearance
-
Some thesis volumes scanned as part of the digitisation scheme funded by Dr Leonard Polonsky are currently unavailable due to sensitive material or uncleared third-party copyright content. We are attempting to contact authors whose theses are affected.
- Publisher:
- Future Medicine Publisher's website
- Journal:
- Biomarkers in Medicine Journal website
- Volume:
- 12
- Issue:
- 7
- Pages:
- 693-696
- Publication date:
- 2018-06-01
- Acceptance date:
- 2018-05-18
- DOI:
- EISSN:
-
1752-0371
- ISSN:
-
1752-0363
- Pubs id:
-
pubs:856277
- URN:
-
uri:42b53360-e76b-4237-a174-95806c2df3a4
- UUID:
-
uuid:42b53360-e76b-4237-a174-95806c2df3a4
- Local pid:
- pubs:856277
- Copyright holder:
- Future Medicine Ltd
- Copyright date:
- 2018
- Notes:
- © 2018 Future Medicine Ltd. This is the accepted manuscript version of the article. The final version is available online from Future Medicine at: https://doi.org/10.2217/bmm-2018-0149
Journal article
Progress and new frontiers in biomarkers for amyotrophic lateral sclerosis
Actions
Access Document
Why is the content I wish to access not available via ORA?
Bibliographic data (the information relating to research outputs) and full-text items (e.g. articles, theses, reports, etc.) arrive in ORA from several different sources. Unfortunately we are not able to make available the full-text for every research output.
Please contact the ORA team (
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
Content may be unavailable for the following four reasons
Alternative access to the full-text
You may be able to access the full-text directly from the publisher's website using the 'Publisher Copy' link in the 'Links & Downloads' box from a research output's ORA record page. This method may require an institutional or individual subscription to the journal/resource.
Authors
Funding
Bibliographic Details
Item Description
Terms of use
If you are the owner of this record, you can report an update to it here: Report update to this record